Morgan Stanley (MS) April 8, 2026 addendum supersedes earlier Series F prospectuses
Rhea-AI Filing Summary
Morgan Stanley files a prospectus addendum and accompanying prospectus supplement dated April 8, 2026 for Global Medium-Term Notes, Series F, Global Units, Series F and Global Warrants, Series F. The addendum clarifies that the April 8, 2026 prospectus and supplement supersede earlier versions for market-making transactions.
Positive
- None.
Negative
- None.
Key Figures
Registration Statement No.: 333-293641
Prospectus / Supplement Date: April 8, 2026
Series: Series F
3 metrics
Registration Statement No.
333-293641
cover prospectus addendum
Prospectus / Supplement Date
April 8, 2026
accompanying prospectus and prospectus supplement
Series
Series F
Global Medium-Term Notes, Global Units, Global Warrants
Key Terms
prospectus supplement, market-making transactions, Global Medium-Term Notes
3 terms
prospectus supplement regulatory
"the accompanying prospectus supplement dated April 8, 2026 relating to Global Medium-Term Notes"
A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.
market-making transactions market
"used in connection with market-making transactions of notes, units or warrants"
Global Medium-Term Notes financial
"GLOBAL MEDIUM-TERM NOTES, SERIES F GLOBAL UNITS, SERIES F GLOBAL WARRANTS, SERIES F"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does Morgan Stanley's April 8, 2026 prospectus addendum for MS cover?
It updates and supersedes earlier prospectuses and supplements. The addendum states the April 8, 2026 prospectus and prospectus supplement replace earlier dated versions for Global Medium-Term Notes, Series F, Global Units, Series F and Global Warrants, Series F used in market-making transactions.
Will Morgan Stanley receive proceeds from the market-making transactions in this addendum (MS)?
The addendum describes market-making use of the prospectus materials. It does not state proceeds treatment or issuance of new securities; the language focuses on which prospectus supplement and prospectus supersede earlier versions for market-making transactions.
Are the Series F notes, units or warrants insured or bank obligations (MS)?
No, they are not insured or bank obligations. The addendum explicitly states the offered notes, units or warrants are not deposits or savings accounts, not FDIC insured, and are not obligations of or guaranteed by any bank or governmental agency.
What should investors read when offered Series F securities under MS filings?
Read the specific pricing or prospectus supplement with the April 8, 2026 prospectus. The addendum instructs readers to read the specific terms in the pricing or prospectus supplement together with the April 8, 2026 prospectus supplement and prospectus, which supersede earlier versions.
